XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

EARNINGS (LOSS) PER COMMON SHARE | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
EARNINGS (LOSS) PER COMMON SHARE | The computation of basic and diluted earnings (loss) per common share for the three months ended March 31, 2024 and 2023 was as follows:
Basic Earnings (Loss) Per Common Share |  | Three Months Ended |  |
(in millions, except per share amounts) |  | 2024 |  | 2023 |  |  |  |
Net income (loss) attributable to Dentsply Sirona |  | $ | 18 |  |  | $ | (19) |  |  |  |  |
Weighted average common shares outstanding |  | 207.4 |  |  | 214.5 |  |  |  |  |
Earnings (loss) per common share - basic |  | $ | 0.09 |  |  | $ | (0.09) |  |  |  |  |
Diluted Earnings (Loss) Per Common Share |  | Three Months Ended |  |
(in millions, except per share amounts) |  | 2024 |  | 2023 |  |  |  |
Net income (loss) attributable to Dentsply Sirona |  | $ | 18 |  |  | $ | (19) |  |  |  |  |
Weighted average common shares outstanding |  | 207.4 |  |  | 214.5 |  |  |  |  |
Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards |  | 1.1 |  |  | — |  |  |  |  |
Total weighted average diluted shares outstanding |  | 208.5 |  |  | 214.5 |  |  |  |  |
Earnings (loss) per common share - diluted |  | $ | 0.09 |  |  | $ | (0.09) |  |  |  |  |
Weighted average shares excluded from diluted common shares outstanding due to reported net loss for the period |  | — |  |  | 1.4 |  |  |  |  |
Weighted average shares excluded from diluted common shares outstanding due to antidilutive nature |  | 3.3 |  |  | 3.8 |  |  |  |  |
On November 7, 2023, the Board of Directors approved an increase to the authorized share repurchase program of $1.0 billion. Share repurchases may be made through open market purchases, Rule 10b5-1 plans, accelerated share repurchases, privately negotiated transactions or other transactions in such amounts and at such times as the Company considers appropriate based upon prevailing market and business conditions and other factors. At March 31, 2024, the Company had authorization to repurchase $1.44 billion in shares of common stock remaining under the share repurchase program.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration